Suppr超能文献

晚期人类前列腺癌中的基因扩增

Gene amplifications in advanced-stage human prostate cancer.

作者信息

Fournier G, Latil A, Amet Y, Abalain J H, Volant A, Mangin P, Floch H H, Lidereau R

机构信息

Service d'Urologie, Hôpital Morvan, Brest, France.

出版信息

Urol Res. 1995;22(6):343-7. doi: 10.1007/BF00296872.

Abstract

Gene amplification is a model of proto-oncogene alterations occasionally observed in human tumors. This amplification can, in some cases, have prognostic value (N-myc in neuroblastoma, c-erbB2 and int-2 in breast cancer, etc.). Amplifications of the proto-oncogenes c-myc, c-erbB2 and int-2 have not yet been report in prostate adenocarcinoma, which, like breast cancer, is hormone dependent. We sought amplifications of these three proto-oncogenes by means of Southern blotting in 15 human prostate adenocarcinoma specimens, most of which were advanced (7 stage C and 6 stage D1 or D2). We confirmed the lack of c-myc and c-erbB2 amplification, regardless of the stage, in contrast to the case of breast cancer. Int-2 amplification was observed in one advanced tumor with bone metastases, out of a total of six stage D tumors. The precise frequency of int-2 amplification and its role in prostate carcinogenesis remain to be determined.

摘要

基因扩增是人类肿瘤中偶尔观察到的原癌基因改变模式。在某些情况下,这种扩增可能具有预后价值(如神经母细胞瘤中的N-myc、乳腺癌中的c-erbB2和int-2等)。原癌基因c-myc、c-erbB2和int-2的扩增在前列腺腺癌中尚未见报道,前列腺腺癌与乳腺癌一样,是激素依赖性的。我们通过Southern印迹法在15例人类前列腺腺癌标本中寻找这三种原癌基因的扩增情况,其中大多数标本处于晚期(7例C期和6例D1或D2期)。与乳腺癌不同,无论处于何阶段,我们均证实缺乏c-myc和c-erbB2扩增。在总共6例D期肿瘤中,有1例伴有骨转移的晚期肿瘤观察到int-2扩增。int-2扩增的确切频率及其在前列腺癌发生中的作用仍有待确定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验